OBJECTIVE: Several obese subjects show a wide array of respiratory disturbances during sleep due to an increased upper-airway resistance. The aim of the present study was to evaluate diurnal PaCO 2 tension in nonsmoking obese women and the possible relationship of this parameter with the presence of sleep disordered breathing (SDB). DESIGN: Cross-sectional study of PaCO 2 tension in obese women. PATIENTS AND METHODS: A total of 91 nonsmoking obese women (BMI Z30 kg/m 2 , aged 42.8715.7 y) were recruited and evaluated for general and anthropometric parameters, respiratory function, sleep-related symptoms, and sleep disorders of breathing. RESULTS: A total of 10 subjects (10.9%) had diurnal hypercapnia (PaCO 2 Z43 mmHg). Age, BMI, neck circumference, apnoea/ hypopnoea index, and nocturnal desaturation (expressed as TST SaO 2o90% ; TST SaO 2o90% ¼ percentage of total sleep time with oxyhaemoglobin saturation o90%) were significantly higher in obese patients with diurnal hypercapnia, compared to normocapnic women. Moreover, hypercapnic patients had reduced forced expiratory volume in 1 s compared to normocapnic individuals. By using multiple regression analysis, the best fitting model (r ¼ 0.62, Po0.001) for predicting diurnal PaCO 2 tension in the study population showed that 24.23% of the variance may be explained by TST SaO 2o90% , according to the equation: PaCO 2 ¼ 0.09 age+0.07 TST SaO 2o90% +33.00. CONCLUSIONS: This study suggests that severity of SDB is the most important factor in determining diurnal PaCO 2 tension in apparently healthy nonsmoking obese women.
Introduction
Studies performed by conventional respiratory function tests demonstrated mild effects of body fatness on respiratory performance, unless obesity is extreme.
1,2 A reduction in expiratory reserve volume (ERV) and mild respiratory volume restriction are well established. Therefore, ventilation can be reduced at lung bases, mainly in patients with reduced ERV, leading to arterial hypoxaemia. 3 Several studies on diurnal hypoventilation in patients affected by obesity hypoventilation syndrome (OHS) have been performed, [4] [5] [6] whereas few data exist on diurnal PaCO 2 tension in apparently healthy nonsmoking obese patients. 7 It is noteworthy that several studies demonstrated a wide array of respiratory disturbances during sleep (hypoventilation, obstructive apnoea-hypopnoea events, and 'flow limitation') in obese individuals, 8, 9 but no information is available about the possible relationship between diurnal PaCO 2 tension and sleep-respiratory disturbances. Therefore, the aims of the present study were (i) to evaluate diurnal PaCO 2 tension in a population of apparently healthy nonsmoking obese women referring to the Outpatient Clinic for the Study of Obesity of our Institution only for a weight-reducing programme, and (ii) to examine the relationship of this parameter with sleep disordered breathing (SDB).
Subjects and methods

Patients
Obese women (body mass index (BMI) Z30 kg/m 2 ), aged 18-70 y, were consecutively enrolled over a 5-y period at the Outpatient Clinic for the Study of Obesity of the Section of Internal Medicine, Endocrinology, and Metabolic Diseases, Department of Emergency and Organ Transplantation, University of Bari, School of Medicine. After clinical history investigation and a complete physical examination, including neurological, cardiopulmonary, and ear, nose, and throat evaluation, subjects with previous diagnosis of sleep apnoea or spontaneously complaining of symptoms or signs of sleep apnoea were excluded. Further exclusion criteria were presence of endocrine diseases, narcolepsy or idiopathic hypersomnia, neuromuscular diseases, psychiatric disorders, overt cardiopulmonary disease, airway obstruction (FEV 1 / FVCo70%; FEV 1 ¼ forced expiratory volume in 1 s, FVC ¼ forced vital capacity) anatomic maxillomandibularskeletal abnormalities, ear, nose, and throat pathology, abuse of alcohol or assumption of any kind of drugs. In particular, to avoid metabolic alchalosis (being able to influence ventilatory response), none of the patients was using loopdiuretics. Moreover, none of the participants had previous diagnosis of diabetes mellitus or a positive clinical history of stroke, transient ischaemic attack, angina pectoris, heart infarction, 'claudicatio intermittens', or congenital heart disease. Finally, smokers were excluded from the study, in order to avoid the possible confounding effect of smoking status on respiratory function. Therefore, 91 obese women who fulfilled both inclusion and exclusion criteria were included in the study. It is noteworthy that about 50% of study subjects were morbidly obese (BMI Z40 kg/m 2 ). Clinical examination consisted of pulmonary function tests, ECG, and thyroid echography. None of the women was pregnant and 36/91 (39.6%) were postmenopausal. Premenopausal women were tested in the luteal phase to avoid the influence of menstrual cycle on breathing control. Biochemical markers of thyroid, liver, and kidney function were within the normal range in all individuals. During the testing period, all subjects were asked to keep their normal mixed diet and not to perform any sporting activity.
Anthropometric parameters
Central-fat accumulation was evaluated by the waist circumference, measured as the midway between the lower-rib margin and the superior anterior iliac spine. 10 Hip circumference was evaluated as the widest circumference over the greater trochanter. 10 The waist-to-hip ratio (WHR) was also calculated. Neck circumference was determined at the level of the cricothyroid membrane. 10 Blood pressure was recorded on at least three different occasions, using a mercury manometer with an appropriate cuff size. The diagnosis of hypertension was defined as the use of antihypertensive drugs or the presence of resting blood pressure 4140 mmHg for systolic blood pressure and/or 490 mmHg for diastolic blood pressure.
Respiratory function data A flow-volume spirometry was performed with the patient in the sitting position and by using a pneumotachograph spyrometer connected to a microcomputer system (PK, Morgan Ltd, Gillingham, Kent, England). The values reported by Vilijanen et al 11 were used as reference. The FEV 1 and the FVC were measured, and the FEV 1 /FVC ratio was also calculated. The maximum expiratory flow at small lung volume (Vmax 25% ) and ERV were also evaluated. The total lung capacity (TLC) was measured by the helium equilibration method, using a pulmonary function laboratory 2400' (Sensor Medics, Bilthooven, The Netherlands). The mean of three different determinations was recorded for all of the above parameters. Arterial blood samples were drawn from brachial or radial artery for blood-gas analysis, after the patients had been in the supine position for at least 3 min. Arterial blood PaCO 2 , PaO 2 , pH, and base excess were analysed by an automatic acid-base analyser (ABL 30 Radiometer, Copenhagen, Denmark). We defined hypercapnia as PaCO 2 Z43 mmHg, according to Laaban et al. 12 The measurement of PaCO 2 and PaO 2 was performed 7 days before the sleep study and repeated at the onset of the study under the same conditions.
Measurement of sleep-related symptoms
Patients were asked to quantify the frequency of symptoms of snoring and sleepiness using a five-point scale (patient score), according to the 'Sleep and Health Questionnaire', 13 that included the following answers: never ¼ 0; rarely (occurring less than once per week) ¼ 1; sometimes (1-2 times per week) ¼ 2; frequently (3-4 times per week) ¼ 3; always or almost always (5-7 times per week) ¼ 4. We defined snoring or excessive daytime sleepiness (EDS) as a patient score Z2. Finally, the Epworth Sleepiness Scale (ESS) was used to measure the sleep propensity. 14 Each study woman was interviewed in the presence of either her partner, when available, or at least one parent or relative, when partner was lacking, in order to get reliable information about snoring.
Measurement of sleep disorders of breathing
All subjects were evaluated in the Sleep Laboratory of the Section of Respiratory Diseases, Department of Clinical Methodology and Medical-Surgical Technologies, University of Bari School of Medicine for one night, and they were monitored continuously for 8 h using a 12-channel polysomnograph (Vitalog HMS 5000, Vitalog Monitoring Inc., Redwood City, CA, USA). A polysomnography was performed after a night of adaptation in the hospital. Electroencephalographic, electro-oculographic, and chin electromyographic recordings were obtained with surface Diurnal PaCO 2 tension in obese women O Resta et al electrodes according to standard methods. Airflow was monitored by a thermistor placed at the nose and mouth. Abdominal and ribcage movements were assessed by respiratory inductive plethysmography. All night recordings of haemoglobin oxygen saturation were obtained by finger pulse oxymetry. Snoring sounds (recorded by a microphone attached to the neck), electrocardiography, and sleep position were also recorded. Transcutaneous CO 2 was measured by a radiometer apparatus (Radiometer TC 100, Copenhagen, Denmark). Apnoea was defined as the cessation of airflow at the nose and mouth lasting at least 10 s. Hypopnoea was defined as a decrease in airflow rib cage and abdominal excursion by 450%, associated with an oxygen desaturation at least 4% below the percentage value. Since more than 85% of respiratory events were obstructive (ie events in which respiratory effort was present), the specific pattern of apnoea episodes was not taken into account in the statistical analysis. In this respect, because it is difficult to get accurate measurements of chest wall movements in obese patients, chest movements were directly verified through the night by visual observation, using a video camera sensitive to ultraviolet light. 15 The number of events per hour was obtained by dividing the total events by the total sleep time (TST) and was defined as the apnoea--hypoapnoea index (AHI). Oxyhaemoglobin desaturation was evaluated in terms of percentage of total sleep time with oxyhaemoglobin saturation o90% (TST SaO2o90% ). Sleep hypoventilation (SHV) was defined as a period of substantial, persistent (42 min) decline (410%) in oxygen saturation, without evidence of upper airway obstruction or arousals, associated with a significant increase of transcutaneous CO 2 Z7 mmHg. SDB was defined either as an AHI 410 events per hour of sleep or as evidence of sustained hypoventilation. The sleep record was scored according to standardized criteria. 16 
Statistical analysis
Statistical analysis was performed using the STATISTICA s 6.0 for Windows, StatSoft Inc. (1995) software (Tulsa, OK, USA). Results are presented as mean7standard deviation (s.d.) for all parameters. Differences between the two groups for continuous and dichotomized variables were evaluated using Student's t-test for independent samples and w 2 -test, respectively. Pearson's correlation coefficients were used to quantify the univariate associations among variables. The relation of PaCO 2 tension with the other study parameters was also examined by linear regression analysis. Multivariate adjustment was performed by forced entry of a set of covariates. Each of the variables was entered into the multiple regression analysis in accordance with its F value, until all variables with a significant F value (Po0.05) had been entered.
The minimal statistical significance was defined for Po0.05. Table 1 shows anthropometric, respiratory, and polysomnographic data in normocapnic and hypercapnic patients. Age, BMI, and neck circumference were higher in hypercapnic patients compared to normocapnic subjects, and most of them (nine out of 10) were postmenopausal. Moreover, obese hypercapnic patients had worse respiratory function, as expressed by reduced FEV 1 , whereas FVC % of predicted, Diurnal PaCO 2 tension in obese women O Resta et al TLC % of predicted, ERV % of predicted, and Vmax 25% % of the predicted were not significantly different between the two groups. Mean PaO 2 in hypercapnic patients was significantly lower than in normocapnic patients. In addition, hypercapnic subjects had significantly higher AHI and TST SaO2o90% values than normocapnic patients. Noteworthy is the fact that AHI 410 was present in nine hypercapnic patients. SHV was present in 7/10 (70%) hypercapnic subjects and, in one of them, it was the main SDB. Table 2 shows the correlation coefficients of PaCO 2 with anthropometric and respiratory parameters in study subjects. PaCO 2 was positively associated with age, BMI, neck circumference, waist circumference, AHI, TST SaO2o90% , and negatively correlated with FEV 1 % of the predicted, FVC % of the predicted, and PaO 2 . When a stepwise multiple regression analysis was performed to identify the factors contributing to increased PaCO 2 , the best fitting model (R ¼ 0.44, Po0.001) for predicting diurnal PaCO 2 tension in study subjects showed that TST SaO2o90% and AHI accounted for 24.33 and 20.10% of the total variance of the dependent variable, respectively, according to the following equation: PaCO 2 ¼ 0.099 TST SaO2o90% +36.121. Even after including alternatively either TST SaO2o90% or AHI among the independent variables of the multivariate analysis, in order to avoid the risk of collinearity, the former (TST SaO2o90% ) remained the stronger predictor of PaCO 2 tension (data not shown).
Results
FEV
Discussion
Our study, performed in a group of 91 nonsmoking obese women, aged 42.8715.7 y, without airway obstruction (FEV 1 /FVC ratio 470%), demonstrates that 10.9% of patients affected by morbid obesity have an increase of diurnal PaCO 2 tension.
Obese hypercapnic subjects were more obese and older, most of them being postmenopausal, and had worse pulmonary function and polysomnographic data than normocapnic subjects. Moreover, we reported a significant correlation between diurnal PaCO 2 and anthropometric, respiratory, and polysomnographic parameters. TST SaO2o90% was the strongest correlate of PaCO 2 tension in hypercapnic subjects, and the stepwise multiple regression analysis showed that the severity of sleep desaturation plays the main role in determining diurnal PaCO 2 tension in these obese women.
Few data exist on diurnal hypoventilation in obese patients; moreover, these findings are from patients with a diagnosis of OHS, characterized by morbid obesity, diurnal hypoventilation (PaCO 2 445 mmHg), hypersomnolence, plethora or oedema, and otherwise unexplained cardiorespiratory failure and chronic hypercapnia. 9, 17, 18 In 60 healthy obese men with normal FEV 1 /FVC ratio and with age and BMI similar to those of our study subjects, Sahebjami and Gartside 7 showed that 25% of them suffered from unexpected hypercapnia and were affected by more severe abnormalities of respiratory function.
To the best of our knowledge, this is the first study concerning diurnal PaCO 2 tension in apparently healthy obese women referring to an Obesity Centre only with the aim of reducing their weight. In particular, an outstanding result of our study is that several obese patients, even though having some features of SDB, such as snoring and excessive daytime sleepiness (56.0 and 42.8%, respectively, in our study population), do not spontaneously refer to a Sleep Clinic, but only to an Obesity Centre for a weight-reducing programme. Therefore, these findings suggest that obesity specialists must carry out an accurate investigation about sleep disorders of breathing, in order to highlight even mild disturbances and, consequently, address the patient to a sleep specialist before such abnormalities become more severe and clinically apparent.
The agreement between our data and those of Sahebjami and Gartside 7 seems to suggest that the increase of PaCO 2 tension in healthy obese women is less frequent and less important than in men of similar age and BMI. We would like to suggest that the discrepancy between men and women (confirmed by our unpublished data) may be due to differences in fat distribution (mainly subcutaneous in women and visceral in men) and hormonal milieu, and to a higher prevalence and severity of sleep-respiratory disturbances in obese males. 8 Indeed, visceral fat, rather than overall adiposity, has been demonstrated to predispose to the development of sleep apnoea in obese individuals. 19 In particular, it has been shown that sleep apneics obese patients have significantly higher amount of visceral fat, compared to nonsleep apneics obese controls, even though there was no difference between the two groups in terms of Diurnal PaCO 2 tension in obese women O Resta et al BMI, as well as the amount of both total and subcutaneous body fat. 19 Furthermore, it is well established that human abdominal visceral adipose tissue releases more inflammatory cytokines, such as interleukin-6 (IL-6) and tumour necrosis factor-a (TNF-a), compared to subcutaneous adipose tissue. 20 In this respect, it is worth noting that the above adipokines may mediate daytime sleepiness associated with disorders of EDS. 21 The diurnal increase of PaCO 2 tension in obese patients is likely to be due, at least in part, to a mechanical problem induced by excessive fat accumulation in the thorax or around upper airway. A reduced lung function of variable degree was found in subjects with severe obesity and OHS. 3, 17 In aggreement with our data, Sahebjiami and Gartside 7 demonstrated that obese subjects with hypercapnia, in the absence of any other disease process and with normal FEV 1 /FVC, were characterized by higher BMI and worse respiratory function. However, not only body weight, but also the fat distribution has been found to play a pivotal role in determining the reduction of FVC in obese subjects.
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A direct correlation between obesity and PaCO 2 has not been reported previously; however, a relationship between body fatness (both total and central) and reduction of lung function, with consequent hypercapnia, is likely to exist. Moreover, weight loss has been demonstrated to cause a significant improvement of respiratory function and hypercapnia. 23, 24 Alternatively, the role of central nervous system has been hypothesized. Indeed, an impairment of ventilatory response to hypercapnia and hypoxaemia has been demonstrated in patients with OHS, with this defect being able to play a role in the development of chronic hypercapnia. 25, 26 The role of SDB in the development of diurnal hypercapnia in obesity is rather controversial. Although we found that oxygen desaturation during sleep (ie TST SaO2o90% ) plays a major role in the development of daytime hypercapnia in obese women, the mechanism responsible for the relationship between nocturnal hypoxaemia and the daytime level of PaCO 2 is still unknown. In addition, a lower daytime PaO 2 , due to decreased lung volume and sleep fragmentation in obese patients, 27 may affect the respiratory central control.
Leptin and insulin might have a role in determining higher daytime PaCO 2 tension in obese subjects. With regard to leptin, recent studies have shown that ob protein replacement reverses the hypoventilation occurring in leptin-deficient ob/ob mouse. 28, 29 In fact, leptin treatment has been shown to prevent respiratory depression in mice, particularly during sleep, and to increase the hypercapnic ventilatory response (HCVR) during non-REM and REM sleep, frequently depressed both in animal and human obesity. These data suggest that leptin deficiency, or leptin resistance in central nervous system, may induce hypoventilation in some obese subjects, thus raising the possibility of an interplay among obesity, leptin, respiratory control, severity of SDB, and diurnal PaCO 2 . In this respect, Phipps et al 30 showed that hypercapnic patients with a similar degree of adiposity and AHI had significantly higher fasting serum leptin levels than eucapnic patients; furthermore, serum leptin levels were a predictor of the presence of hypercapnia. On the contrary, insulin is unlikely to play a central role in respiratory control; indeed, Polotsky et al 31 found no significant difference in insulin levels between diabetic (depressed HCVR) and nondiabetic (normal HCVR) mice.
In conclusion, the present study, performed in a group of apparently healthy nonsmoking obese women without airway obstruction, demonstrates that an increase of diurnal PaCO 2 tension is present in 10.9% of patients. The severity of SDB, present in about 40% of our study subjects with nocturnal respiratory alterations (such as apnoea, hypopnoea, and sleep hypoventilation) and expressed by nocturnal oxygen desaturation, is the most important determinant of diurnal PaCO 2 tension.
